U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 10:31:58 GMT 2025
Edited
by admin
on Wed Apr 02 10:31:58 GMT 2025
Protein Type MONOCLONAL ANTIBODY CONJUGATE
Protein Sub Type IGG1|KAPPA
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
4WQE3D6M5H
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Mozistobart Zoratolimod
INN  
Official Name English
H-gamma1 heavy chain humanized (1-460) [VH (Homo sapiens IGHV3-48*03 (89.8%) -(IGHD) -IGHJ4*01 (85.7%) Q120>R (115), CDR-IMGT [8.8.16] (26-33.51-58.97-112)) (1-123) -Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14, G1v14-1 CH2 A1.3, A1.2
Preferred Name English
Immunoglobulin G1 [240-alanine,241-alanine,243-alanine], anti-(human/Macaca fascicularis sialic acid-binding Ig-like lectin 2) (human-Mus musculus monoclonal Ab-125 ?1-chain) fusion protein with peptide (RPEGFGPP), disulfide with human-Mus musculus monoc
Common Name English
mozistobart zoratolimod [INN]
Common Name English
immunoglobulin G1-kappa, anti-[Homo sapiens CD22 (sialic acid binding Ig-like lectin 2, SIGLEC2, SIGLEC-2, B-lymphocyte cell adhesion molecule, BL-CAM, Leu-14)], humanized monoclonal antibody; conjugated at one glutamine residue with zoratolimod
Common Name English
Code System Code Type Description
SMS_ID
300000054735
Created by admin on Wed Apr 02 10:31:58 GMT 2025 , Edited by admin on Wed Apr 02 10:31:58 GMT 2025
PRIMARY
CAS
2852752-99-7
Created by admin on Wed Apr 02 10:31:58 GMT 2025 , Edited by admin on Wed Apr 02 10:31:58 GMT 2025
PRIMARY
INN
12947
Created by admin on Wed Apr 02 10:31:58 GMT 2025 , Edited by admin on Wed Apr 02 10:31:58 GMT 2025
PRIMARY
NCI_THESAURUS
C190597
Created by admin on Wed Apr 02 10:31:58 GMT 2025 , Edited by admin on Wed Apr 02 10:31:58 GMT 2025
PRIMARY
FDA UNII
4WQE3D6M5H
Created by admin on Wed Apr 02 10:31:58 GMT 2025 , Edited by admin on Wed Apr 02 10:31:58 GMT 2025
PRIMARY
From To
1_22 1_96
2_22 2_96
2_150 2_206
2_226 4_214
2_267 2_327
1_150 1_206
2_373 2_431
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
1_226 3_214
1_232 2_232
1_235 2_235
1_267 1_327
1_373 1_431
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_303
N 2_303
Related Record Type Details
TARGET->LIGAND
PRECLINICAL
PARENT -> CONJUGATE
Related Record Type Details
ACTIVE MOIETY
mmunostimulant

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION [1_455] Glutamyl zoratolimod P6HAB4JR9K
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL